RGNX logo

REGENXBIO (RGNX) Revenue

Annual Revenue

$90.24 M
-$22.48 M-19.94%

December 31, 2023

Summary

Performance

1-Year Change

-19.94%

3-Year Change

-41.62%

5-Year Change

-58.7%

15-Year Change

+768.3%

RGNX Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

56.01%
RGNX annual revenue is higher than 56.01% of companies in Healthcare sector

Analysts Estimate

$86.85 M
RGNX annual revenue is currently +3.90% higher than the consensus analysts' forecast

High & Low

All-time High

$470.35 M
RGNX annual revenue is currently -80.81% below its historical high of $470.35 million

3-Year Low

$90.24 M
RGNX annual revenue is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
RGNX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 27, 2025
RGNX next annual earnings announcement is scheduled for Feb 27, 2025

OtherRGNXprofitabilitymetrics:

Annual EPS

-$6.02
RGNX annual earnings per share is -$6.02

Annual Net Income

-$263.49 M
RGNX annual net profit is -$263.49 million

Annual Operating Profit

-$268.13 M
RGNX annual operating income is -$268.13 million

Annual Gross Profit

$53.03 M
RGNX annual gross profit is $53.03 million

Quarterly Revenue

$24.20 M
+$1.90 M+8.53%

September 30, 2024

Summary

Performance

3-Month Change

+8.53%

1-Year Change

+8.53%

3-Year Change

-21.37%

5-Year Change

+64.61%

RGNX Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

51.79%
RGNX quarterly revenue is higher than 51.79% of companies in Healthcare sector

Analysts Estimate

$23.37 M
RGNX quarterly revenue is currently +3.53% higher than the consensus analysts' forecast

High & Low

All-time High

$398.65 M
RGNX quarterly revenue is currently -93.93% below its historical high of $398.65 million

3-Year Low

$15.62 M
RGNX quarterly revenue is currently +54.89% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
RGNX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 27, 2025
RGNX next earnings announcement is scheduled for Feb 27, 2025

Related metrics

Quarterly Gross Profit

$11.81 M
RGNX quarterly gross profit is $11.81 million

Quarterly Operating Profit

-$62.08 M
RGNX quarterly operating income is -$62.08 million

Quarterly Net Income

-$59.60 M
RGNX quarterly net profit is -$59.60 million

Quarterly EPS

-$1.17
RGNX quarterly earnings per share is -$1.17

TTM Revenue

$84.33 M
-$4.72 M-5.30%

September 30, 2024

Summary

Performance

3-Month Change

-5.3%

1-Year Change

-5.3%

3-Year Change

-9.46%

5-Year Change

+139.34%

RGNX TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

50.06%
RGNX TTM revenue is higher than 50.06% of companies in Healthcare sector

Analysts Estimate

$85.49 M
RGNX TTM revenue is currently -1.35% lower than the consensus analysts' forecast

High & Low

All-time High

$484.30 M
RGNX TTM revenue is currently -82.59% below its historical high of $484.30 million

3-Year Low

$84.33 M
RGNX TTM revenue is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
RGNX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 27, 2025
RGNX next earnings announcement is scheduled for Feb 27, 2025

OtherRGNXprofitabilitymetrics:

TTM Gross Profit

$45.84 M
RGNX TTM gross profit is $45.84 million

TTM Operating Profit

-$243.78 M
RGNX TTM operating income is -$243.78 million

TTM Net Income

-$238.81 M
RGNX TTM net profit is -$238.81 million

TTM EPS

-$5.02
RGNX TTM earnings per share is -$5.02

RGNX Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-19.9%+8.5%-5.3%
3 y3 years-41.6%-21.4%-9.5%
5 y5 years-58.7%+64.6%+139.3%

RGNX Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-80.8%at low-93.9%+54.9%-82.6%at low
5 y5-year-80.8%+156.1%-93.9%+105.6%-82.6%+139.3%
alltimeall time-80.8%+1866.5%-93.9%>+9999.0%-82.6%>+9999.0%

REGENXBIO Revenue History

DateAnnualQuarterlyTTM
Sep 2024
-
$24.20 M(+8.5%)
$84.33 M(-5.3%)
Jun 2024
-
$22.30 M(+42.7%)
$89.04 M(+2.7%)
Mar 2024
-
$15.62 M(-29.7%)
$86.73 M(-3.9%)
Dec 2023
$90.24 M(-19.9%)
$22.21 M(-23.2%)
$90.24 M(-9.2%)
Sep 2023
-
$28.91 M(+44.7%)
$99.37 M(+2.5%)
Jun 2023
-
$19.98 M(+4.4%)
$96.97 M(-11.6%)
Mar 2023
-
$19.14 M(-38.9%)
$109.64 M(-2.7%)
Dec 2022
$112.72 M(-76.0%)
$31.34 M(+18.2%)
$112.72 M(-76.5%)
Sep 2022
-
$26.51 M(-18.8%)
$480.03 M(-0.9%)
Jun 2022
-
$32.65 M(+46.9%)
$484.30 M(+2.2%)
Mar 2022
-
$22.22 M(-94.4%)
$473.68 M(+0.7%)
Dec 2021
$470.35 M(+204.3%)
$398.65 M(+1195.5%)
$470.35 M(+405.0%)
Sep 2021
-
$30.77 M(+39.7%)
$93.14 M(-42.2%)
Jun 2021
-
$22.04 M(+16.7%)
$161.28 M(+3.5%)
Mar 2021
-
$18.88 M(-11.9%)
$155.81 M(+0.8%)
Dec 2020
$154.57 M(+338.7%)
$21.45 M(-78.3%)
$154.57 M(+6.7%)
Sep 2020
-
$98.91 M(+497.1%)
$144.89 M(+138.8%)
Jun 2020
-
$16.57 M(-6.1%)
$60.68 M(+16.7%)
Mar 2020
-
$17.64 M(+49.9%)
$51.99 M(+47.6%)
Dec 2019
$35.23 M
$11.77 M(-19.9%)
$35.23 M(-45.2%)
Sep 2019
-
$14.70 M(+86.5%)
$64.24 M(+17.1%)
DateAnnualQuarterlyTTM
Jun 2019
-
$7.88 M(+791.5%)
$54.85 M(-37.0%)
Mar 2019
-
$884.00 K(-97.8%)
$87.00 M(-60.2%)
Dec 2018
$218.50 M(+2002.4%)
$40.78 M(+668.5%)
$218.50 M(+21.5%)
Sep 2018
-
$5.31 M(-86.7%)
$179.77 M(+2.3%)
Jun 2018
-
$40.03 M(-69.8%)
$175.80 M(+23.5%)
Mar 2018
-
$132.39 M(+6389.8%)
$142.33 M(+1269.5%)
Dec 2017
$10.39 M(+126.5%)
$2.04 M(+52.7%)
$10.39 M(+3.4%)
Sep 2017
-
$1.34 M(-79.6%)
$10.05 M(+13.7%)
Jun 2017
-
$6.56 M(+1342.2%)
$8.84 M(+90.0%)
Mar 2017
-
$455.00 K(-73.2%)
$4.65 M(+1.4%)
Dec 2016
$4.59 M(-39.5%)
$1.70 M(+1256.8%)
$4.59 M(-37.5%)
Sep 2016
-
$125.00 K(-94.7%)
$7.34 M(-12.1%)
Jun 2016
-
$2.38 M(+504.3%)
$8.36 M(+13.8%)
Mar 2016
-
$393.00 K(-91.2%)
$7.34 M(-3.3%)
Dec 2015
$7.59 M(+24.0%)
$4.45 M(+290.2%)
$7.59 M(+76.8%)
Sep 2015
-
$1.14 M(-16.4%)
$4.29 M(+18.1%)
Jun 2015
-
$1.36 M(+111.6%)
$3.64 M(+59.9%)
Mar 2015
-
$644.00 K(-43.9%)
$2.27 M(+39.5%)
Dec 2014
$6.12 M(+0.5%)
$1.15 M(+137.7%)
$1.63 M(+237.7%)
Sep 2014
-
$483.00 K
$483.00 K
Dec 2013
$6.09 M
-
-

FAQ

  • What is REGENXBIO annual revenue?
  • What is the all time high annual revenue for REGENXBIO?
  • What is REGENXBIO annual revenue year-on-year change?
  • What is REGENXBIO quarterly revenue?
  • What is the all time high quarterly revenue for REGENXBIO?
  • What is REGENXBIO quarterly revenue year-on-year change?
  • What is REGENXBIO TTM revenue?
  • What is the all time high TTM revenue for REGENXBIO?
  • What is REGENXBIO TTM revenue year-on-year change?

What is REGENXBIO annual revenue?

The current annual revenue of RGNX is $90.24 M

What is the all time high annual revenue for REGENXBIO?

REGENXBIO all-time high annual revenue is $470.35 M

What is REGENXBIO annual revenue year-on-year change?

Over the past year, RGNX annual revenue has changed by -$22.48 M (-19.94%)

What is REGENXBIO quarterly revenue?

The current quarterly revenue of RGNX is $24.20 M

What is the all time high quarterly revenue for REGENXBIO?

REGENXBIO all-time high quarterly revenue is $398.65 M

What is REGENXBIO quarterly revenue year-on-year change?

Over the past year, RGNX quarterly revenue has changed by +$1.90 M (+8.53%)

What is REGENXBIO TTM revenue?

The current TTM revenue of RGNX is $84.33 M

What is the all time high TTM revenue for REGENXBIO?

REGENXBIO all-time high TTM revenue is $484.30 M

What is REGENXBIO TTM revenue year-on-year change?

Over the past year, RGNX TTM revenue has changed by -$4.72 M (-5.30%)